Literature DB >> 6194788

Inhibition of cell division by interferons. The relationship between changes in utilization of thymidine for DNA synthesis and control of proliferation in Daudi cells.

D R Gewert, G Moore, M J Clemens.   

Abstract

Inhibition of the proliferation of Daudi cells by exposure to human lymphoblastoid interferons is associated with an early and marked decrease in the incorporation into DNA of exogenous [3H]thymidine when cells are incubated with trace amounts of this precursor. In contrast, incorporation of exogenous deoxyadenosine into DNA is unchanged under the same conditions. Interferon treatment results in a lowering of thymidine kinase activity, an effect which may be largely responsible for the inhibition of incorporation of labelled thymidine into DNA. At higher concentrations of exogenous thymidine, which minimize the contribution of intracellular sources to the dTTP pool, the inhibition of thymidine incorporation is abolished. Under conditions in which exogenous thymidine is rigorously excluded from the medium or, conversely, in which cells are entirely dependent on exogenous thymidine for growth, the magnitude of the inhibition of cell proliferation by interferons is the same as under normal culture conditions. We conclude that, even though cell growth is impaired, the rate of DNA synthesis is not grossly inhibited up to 48 h after commencement of interferon treatment. Furthermore, changes in neither the utilization of exogenous thymidine nor the synthesis of nucleotides de novo are responsible for the effect on cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6194788      PMCID: PMC1152341          DOI: 10.1042/bj2140983

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  Uridine transport in Novikoff rat hepatoma cells and other cell lines and its relationship to uridine phosphorylation and phosphorolysis.

Authors:  P G Plagemann; R Marz; R M Wohlhueter
Journal:  J Cell Physiol       Date:  1978-10       Impact factor: 6.384

2.  The effects of interferon on epidermal growth factor action.

Authors:  S L Lin; P O Ts'o; M D Hollenberg
Journal:  Biochem Biophys Res Commun       Date:  1980-09-16       Impact factor: 3.575

3.  A family of structural genes for human lymphoblastoid (leukocyte-type) interferon.

Authors:  G Allen; K H Fantes
Journal:  Nature       Date:  1980-10-02       Impact factor: 49.962

4.  A monoclonal antibody for large-scale purification of human leukocyte interferon.

Authors:  D S Secher; D C Burke
Journal:  Nature       Date:  1980-06-12       Impact factor: 49.962

5.  Effect of sodium butyrate on the antiviral and anticellular action of interferon in normal and MSV-transformed cells.

Authors:  M F Bourgeade; C Chany
Journal:  Int J Cancer       Date:  1979-09-15       Impact factor: 7.396

6.  Interferon action: induction of specific proteins in mouse and human cells by homologous interferons.

Authors:  S L Gupta; B Y Rubin; S L Holmes
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

7.  Effects of leukocyte and fibroblast interferon on events in the fibroblast cell cycle.

Authors:  E Lundgren; I Larsson; H Miörner; O Strannegård
Journal:  J Gen Virol       Date:  1979-03       Impact factor: 3.891

8.  Synthesis of new proteins associated with the induction of interferon in human fibroblast cells.

Authors:  N B Raj; P M Pitha
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

9.  Role of G0-G1 arrest in the inhibition of tumor cell growth by interferon.

Authors:  A A Creasey; J C Bartholomew; T C Merigan
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

10.  Inhibition by lymphoblastoid interferon of growth of cells derived from the human breast.

Authors:  F Balkwill; D Watling; J Taylor-Papadimitriou
Journal:  Int J Cancer       Date:  1978-09-15       Impact factor: 7.396

View more
  9 in total

1.  Inhibition of polypeptide chain initiation in Daudi cells by interferons. Evidence that activity of initiation factor eIF-2 and availability of mRNA are unimpaired.

Authors:  M J Clemens; V J Tilleray
Journal:  Biochem J       Date:  1986-08-01       Impact factor: 3.857

2.  Inhibition of cell proliferation by interferons. Relative contributions of changes in protein synthesis and breakdown to growth control of human lymphoblastoid cells.

Authors:  M A McNurlan; M J Clemens
Journal:  Biochem J       Date:  1986-08-01       Impact factor: 3.857

Review 3.  How to optimize the effect of 5-fluorouracil modulated therapy in advanced colorectal cancer.

Authors:  P Ragnhammar; H Blomgren
Journal:  Med Oncol       Date:  1995-09       Impact factor: 3.064

Review 4.  Regulation of cell proliferation and differentiation by interferons.

Authors:  M J Clemens; M A McNurlan
Journal:  Biochem J       Date:  1985-03-01       Impact factor: 3.857

5.  Rate of incorporation of radiolabelled nucleosides does not necessarily reflect the metabolic state of cells in culture: effects of latent mycoplasma contamination.

Authors:  M Merkenschlager; D Kardamakis; F C Rawle; N Spurr; P C Beverley
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

6.  Induction of B-cell differentiation antigens in interferon- or phorbol ester-treated Daudi cells is impaired by inhibitors of ADP-ribosyltransferase.

Authors:  R Exley; J Gordon; M J Clemens
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

7.  Pharmacokinetic interaction of 5-fluorouracil and interferon alpha-2b with or without folinic acid.

Authors:  J b1p6uller; M Czejka
Journal:  Med Oncol       Date:  1995-03       Impact factor: 3.064

8.  A phase II trial of interferon alpha-2A plus fluorouracil in advanced renal cell carcinoma. A Hoosier Oncology Group study.

Authors:  B R Murphy; S M Rynard; L H Einhorn; P J Loehrer
Journal:  Invest New Drugs       Date:  1992-08       Impact factor: 3.850

9.  Regulation of in vitro translation by double-stranded RNA in mammalian cell mRNA preparations.

Authors:  G Pratt; A Galpine; N Sharp; S Palmer; M J Clemens
Journal:  Nucleic Acids Res       Date:  1988-04-25       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.